Business
Why the Alterity (ASX:ATH) share price is skyrocketing 42% today
One of the best performers on the ASX today is the Alterity Therapeutics Ltd (ASX: ATH) share price. Driving the meteoric rise, the biotech company announced positive results for its lead compound, ATH434.
At the time of writing, Alterity shares are swapping hands for 4.25 cents apiece, up 41.67%.
What does Alterity do?
Alterity is an Australian biotech company focused on commercialising research into neurodegenerative disorders. These include Parkinsonian movement disorders, Alzheimer’s disease, Huntington disease and others.
The company’s lead candidate ATH434 is currently in development. It aims to block the aggregation of pathological proteins that cause brain degeneration. Current remedies include medications and lifestyle…
-
General23 hours agoGerman backpacker Carolina Wilga found alive in WA’s outback
-
General12 hours agoThailand punches above its weight in film creativity and cross-border appeal. Here’s why
-
General23 hours agoOfficer-induced jeopardy • Inside Story
-
Noosa News10 hours agoMitch Power Quick Shear event gets men talking about mental health